Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.53 USD | +1.32% | +2.00% | +73.86% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 189M |
---|---|---|---|---|---|
Net income 2024 * | -35M | Net income 2025 * | -41M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.64
x | P/E ratio 2025 * |
-5.09
x | Employees | 12 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.9% |
Latest transcript on Atossa Therapeutics, Inc.
1 day | +1.32% | ||
1 week | +2.00% | ||
Current month | +1.32% | ||
1 month | -23.50% | ||
3 months | +82.23% | ||
6 months | +126.63% | ||
Current year | +73.86% |
Managers | Title | Age | Since |
---|---|---|---|
Shu-Chih Chen
FOU | Founder | 62 | 08-11-30 |
Steven Quay
CEO | Chief Executive Officer | 73 | 08-11-30 |
Heather Rees
DFI | Director of Finance/CFO | - | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Quay
CEO | Chief Executive Officer | 73 | 08-11-30 |
Director/Board Member | 66 | 14-02-28 | |
H. Remmel
BRD | Director/Board Member | 72 | 12-01-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 1.53 | +1.32% | 950,685 |
24-04-30 | 1.51 | -1.31% | 1,451,633 |
24-04-29 | 1.53 | 0.00% | 1,047,842 |
24-04-26 | 1.53 | +0.66% | 900,111 |
24-04-25 | 1.52 | +1.33% | 854,598 |
Delayed Quote Nasdaq, May 01, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+73.86% | 189M | |
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |
- Stock Market
- Equities
- ATOS Stock